Strides Pharma Science: Dr R Anil Kumar, Senior Vice President – Research and Development resigns
Bengaluru: Strides Pharma Science has informed in a BSE filing about the resignation of Dr R Anil Kumar, Senior
Vice President – Research and Development, a Senior Management Personnel of the Company, effective closing business hours of August 28, 2024.
Dr Kumar has resigned to pursue opportunities outside the Company.
Read also: Strides Pharma Science arm incorporates company in New Zealand
Strides, a global pharmaceutical company headquartered in Bengaluru, India, is listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR). The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy and an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry, and two locations in Bengaluru), Italy (Milan), Kenya (Nairobi), and the United States (New York). The Company focuses on “difficult to manufacture” products sold in over 100 countries.
Read also: Strides Pharma Science arm incorporates company in New Zealand
